Abstract
Our study aimed to assess the quality of life (QoL) of patients with congestive heart failure (CHF) and to correlate the different aspects of QoL with relevant socio-demographic variables, CHF severity, somatic comorbidities, other clinical variables and depressive symptomatology. In a cross-sectional study design, a community sample of 103 adult patients with CHF (mean age 68 years, 73 % male) was recruited from an outpatient cardiology practice. CHF severity was assessed with physician ratings of the New York Heart Association (NYHA) functional class and measurement of brain natriuretic peptide (BNP) levels. The psychometric evaluation of quality of life was made using the Medical Outcomes Study Short Form-36 (SF-36) and the Kansas City Cardiomyopathy Questionnaire (KCCQ). The Beck Depression Inventory Second Edition (BDI-II) assessed depressive symptoms. Using multiple linear regression, predictors of poorer QoL included being a female, being older, living alone, NYHA functional class ≥ II, higher levels of BNP comorbidity (such as renal insufficiency and cerebrovascular disease), fluid retention, depressive symptomatology (assessed by BDI-II) and treatment with anti-dyslipidemics, diuretics and β-blockers. Among these correlates, psychological distress was the most strongly related to QoL. Also, functional status measured by NYHA demonstrated a high impact on QoL. Our findings suggest the need to address such factors in developing effective care to improve psychological and functional status in order to enhance QoL in these patients.
Similar content being viewed by others
References
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association.
Bettencourt, P. (2004). NT-proBNP and BNP: biomarkers for heart failure management. European Journal of Heart Failure, 359, 363.
Clark, D., Tu, W., Weiner, M., & Murray, M. (2003). Correlates of health-related quality of life among lower-income, urban adults with congestive heart failure. Heart and Lung, 32(6), 391–401.
Coats, A. J. S., Clarck, A. L., Piepoli, M., Volterrani, M., & Poole-Wilson, P. A. (1994). Symptoms and quality of life in heart failure: the muscle hypothesis. British Heart Journal, 72(suppl), 36–39.
Coelho, R., Martins, A., & Barros, H. (2002). Clinical profiles relating gender and depressive among adolescents ascertained by Beck Depression Inventory. European Psychiatry, 17, 222–226.
Desnos, M. (1997). Qualité de vie et insuffisance cardiaque: la quête du Graal ? Archives des maladies du cœur et des vaisseaux, 90(12), 1575–1576.
Dobre, D., Jongste, M., Haaijer-Ruskamp, F. M., Sanderman, R., van Veldhuisen, D. J., & Ranchor, A. V. (2008). The enigma of quality of life in patients with heart failure. International Journal of Cardiology, 125, 407–409.
Evangelista, L. S., Kagawa-Singer, M., & Dracup, K. (2001). Gender differences in health perceptions and meaning in persons living with heart failure. Heart and Lung, 30, 167–176.
Faller, H., Stork, S., Schuler, M., Schowalter, M., Steinbuchel, T., Ertl, G., et al. (2009). Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure- a structural equation modelling approach. Journal of Cardiac Failure, 15(4), 286–292.
Ferreira, P. (2000a). Criação da Versão portuguesa do MOS SF-36, Parte I- Adaptação Cultural e Linguística. Acta Médica Portuguesa, 13, 55–66.
Ferreira, P. (2000b). Criação da Versão portuguesa do MOS SF-36, Parte II- Testes de validação. Acta Médica Portuguesa, 13, 119–127.
Gottlieb, S. S., Khatta, M., Friedmann, E., Einbinder, L., Katzen, S., Marshall, J., et al. (2004). The influence of age, gender and race on the prevalence of depression in heart failure patients. Journal of the American College of Cardiology, 43(9), 1542–1549.
Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. Journal of the American College of Cardiology, 35, 1245–1255.
Hauptman, P. J., Masoudi, F. A., Weintraub, W. S., Pina, I., Jones, P. G., & Spertus, J. A. (2004). Variability in the clinical status of patients with advanced heart failure. Journal of Cardiac Failure, 10(5), 397–401.
Havranek, E. P., Spertus, J. A., Masoudi, F. A., Jones, P. G., & Rumsfeld, J. S. (2004). Predictors of the onset of depressive symptoms in patients with heart failure. Journal of the American College of Cardiology, 44(12), 2333–2338.
Hoekstra, T., Lesman-Leegte, I., Veldhuisen, D., Sanderman, R., & Jaarsma, T. (2011). Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. European Journal of Heart Failure, 13(9), 1013–1018.
Lesman-Leegte, I., Jaarsma, T., Coyne, J. C., Hillege, H. L., Veldhuisen, D. V., & Sanderman, R. (2009). Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age and gender matched community controls. Journal of Cardiac Failure, 15(1), 17–23.
Luttik, M. L., Lesman-Leegte, I., & Jaarsma, T. (2009). Quality of life and depressive symptoms in heart failure patients and their partners: the impact of role and gender. Journal of Cardiac Failure, 15(7), 580–585.
Mair, J., Friedl, W., & Thomas, S. (1999). Natriuretic peptide in assessment of left ventricular dysfunction. Scandinavian Journal of Clinical and Laboratory Investigation, 230, 132–142.
Martensson, J., Dracup, K., Canary, C., & Fridlund, B. (2003). Living with heart failure: depression and quality of life in patients and spouses. Journal of Heart and Lung Transplantation, 22, 460–467.
Masoudi, F. A., Rumsfeld, J. S., Havranek, E. P., House, J. A., Peterson, E. D., Krumholz, H. M., et al. (2004). Age, functional capacity, and health related quality of life in patients with heart failure. Journal of Cardiac Failure, 10(5), 368–373.
O’Keeffe, S. T., Lye, M., Donnellan, C., & Carmichael, D. N. (1998). Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart, 80, 377–382.
Reddy, P., & Dunn, A. B. (2000). The effect of β-blockers on health–related quality of life in patients with heart failure. Pharmacotherapy, 20(6), 679–689.
Riedinger, M. S., Dracup, K. A., Bretcht, M. L., Padilla, G., Sarna, L., & Ganz, P. A. (2001). Quality of life in patients with heart failure: do gender differences exist? Heart and Lung, 30, 105–116.
Sagnella, G. (1998). Measurement and significance of circulating natriuretic peptide in cardiovascular disease. Clinical Science, 95(5), 519–529.
Seongkum, H., Lennie, T. A., Okoli, C., & Moser, D. K. (2009). Quality of life in patients with heart failure: ask the patients. Heart and Lung, 38, 100–108.
Skotzko, C. E., Krichten, C., Zietowski, G., Alves, L., Freudenberger, R., Robinson, S., et al. (2000). Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. Journal of Cardiac Failure, 6(4), 300–305.
Sneed, N., Paul, S., Michel, Y., VanBakel, A., & Hendrix, G. (2001). Evaluation of 3 quality of life measurement tools in patients with chronic heart failure. Heart and Lung, 30, 332–340.
Soler-Soler, J., & Permanyer-Miralda, G. (1994). How do changes in lifestyle complement medical treatment in heart failure? British Heart Journal, 72, 87–91.
Spertus, J., Green, C., Porter, C., & Bresnahan, D. (2000). The Kansas City Cardiomyopathy Questionnaire predicts heart failure and death. Journal of the American College of Cardiology, 35, 541.
Steptoe, A., Mohabir, A., Mahon, N. G., & McKenna, W. J. (2000). Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart, 83, 645–650.
Valle, R., Aspromonte, N., & Feola, M. (2005). B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. Journal of Cardiac Failure, 11(7), 498–503.
Vanderheyden, M., Bartunek, J., & Goethals, M. (2004). Brain and other natriuretic peptides: molecular aspects. European Journal of Heart Failure, 6(3), 261–268.
Wenger, N. K. (1989). Quality of life: can it should be assessed in patients with heart failure? Cardiology, 76, 391–398.
Worster, P. L., Macko, M. J., & Moser, D. K. (2000). Quality of life in heart failure patients with preserved and non-preserved left ventricular function. Circulation, 102, II-749.
York, K. M., Hassan, M., & Sheps, D. S. (2008). Psychobiology of depression/distressed in congestive heart failure. Heart Failure Reviews, 14, 35–50.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramos, S., Prata, J., Gonçalves, F.R. et al. Congestive Heart Failure and Quality of Life. Applied Research Quality Life 9, 803–817 (2014). https://doi.org/10.1007/s11482-013-9270-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11482-013-9270-6